Inbrija

Product NDC: 0259-6142
11-digit product format: 002596142
Labeler code: 0259
Product ID: 0259-6142_d7dccf06-ab71-4821-bda0-da271532a33d
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: levodopa
Dosage form: CAPSULE
Route: RESPIRATORY (INHALATION)
Labeler: Merz Pharmaceuticals, LLC
Application: NDA209184
Marketing category: NDA
Marketing start: 2018-12-22
Substance: LEVODOPA
Active strength: 42 mg/1
Pharmacologic classes: Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N209184-001	INBRIJA	LEVODOPA	42MG	POWDER / INHALATION		RLD, RS	2018-12-21

Orange Book patents#

Current patent rows page 1 of 1 · 6 matching rows.

Application-product, Patent, Expiration table
Application-product	Patent	Expiration	Use code	Coverage / status	Submission date
N209184-001	RE43711	2029-02-03	U-2484		2019-01-18
N209184-001	8545878	2032-11-16		Drug product	2019-01-18
N209184-001	8685442	2032-11-16		Drug product	2019-01-18
N209184-001	8945612	2032-11-16		Drug product	2019-01-18
N209184-001	9393210	2032-11-16		Drug product	2019-01-18
N209184-001	12458615	2033-10-21	U-2484		2025-11-26

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 42 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	RLD / RS	Approval date	Source SHA-256
2026-08-18 06:07:40	2026-07	N209184-001	INBRIJA	42MG	POWDER / INHALATION	RLD, RS	2018-12-21	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N209184-001	INBRIJA	42MG	POWDER / INHALATION	RLD, RS	2018-12-21	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N209184-001	INBRIJA	42MG	POWDER / INHALATION	RLD, RS	2018-12-21	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N209184-001	INBRIJA	42MG	POWDER / INHALATION	RLD, RS	2018-12-21	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N209184-001	INBRIJA	42MG	POWDER / INHALATION	RLD, RS	2018-12-21	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N209184-001	INBRIJA	42MG	POWDER / INHALATION	RLD, RS	2018-12-21	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N209184-001	INBRIJA	42MG	POWDER / INHALATION	RLD, RS	2018-12-21	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N209184-001	INBRIJA	42MG	POWDER / INHALATION	RLD, RS	2018-12-21	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N209184-001	INBRIJA	42MG	POWDER / INHALATION	RLD, RS	2018-12-21	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N209184-001	INBRIJA	42MG	POWDER / INHALATION	RLD, RS	2018-12-21	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N209184-001	INBRIJA	42MG	POWDER / INHALATION	RLD, RS	2018-12-21	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N209184-001	INBRIJA	42MG	POWDER / INHALATION	RLD, RS	2018-12-21	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N209184-001	INBRIJA	42MG	POWDER / INHALATION	RLD, RS	2018-12-21	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N209184-001	INBRIJA	42MG	POWDER / INHALATION	RLD, RS	2018-12-21	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N209184-001	INBRIJA	42MG	POWDER / INHALATION	RLD, RS	2018-12-21	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N209184-001	INBRIJA	42MG	POWDER / INHALATION	RLD, RS	2018-12-21	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N209184-001	INBRIJA	42MG	POWDER / INHALATION	RLD, RS	2018-12-21	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N209184-001	INBRIJA	42MG	POWDER / INHALATION	RLD, RS	2018-12-21	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N209184-001	INBRIJA	42MG	POWDER / INHALATION	RLD, RS	2018-12-21	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N209184-001	INBRIJA	42MG	POWDER / INHALATION	RLD, RS	2018-12-21	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N209184-001	INBRIJA	42MG	POWDER / INHALATION	RLD, RS	2018-12-21	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N209184-001	INBRIJA	42MG	POWDER / INHALATION	RLD, RS	2018-12-21	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N209184-001	INBRIJA	42MG	POWDER / INHALATION	RLD, RS	2018-12-21	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N209184-001	INBRIJA	42MG	POWDER / INHALATION	RLD, RS	2018-12-21	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N209184-001	INBRIJA	42MG	POWDER / INHALATION	RLD, RS	2018-12-21	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N209184-001	INBRIJA	42MG	POWDER / INHALATION	RLD, RS	2018-12-21	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N209184-001	INBRIJA	42MG	POWDER / INHALATION	RLD, RS	2018-12-21	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N209184-001	INBRIJA	42MG	POWDER / INHALATION	RLD, RS	2018-12-21	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	N209184-001	INBRIJA	42MG	POWDER / INHALATION	RLD, RS	2018-12-21	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	N209184-001	INBRIJA	42MG	POWDER / INHALATION	RLD, RS	2018-12-21	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	N209184-001	INBRIJA	42MG	POWDER / INHALATION	RLD, RS	2018-12-21	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	N209184-001	INBRIJA	42MG	POWDER / INHALATION	RLD, RS	2018-12-21	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	N209184-001	INBRIJA	42MG	POWDER / INHALATION	RLD, RS	2018-12-21	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	N209184-001	INBRIJA	42MG	POWDER / INHALATION	RLD, RS	2018-12-21	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	N209184-001	INBRIJA	42MG	POWDER / INHALATION	RLD, RS	2018-12-21	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	N209184-001	INBRIJA	42MG	POWDER / INHALATION	RLD, RS	2018-12-21	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	N209184-001	INBRIJA	42MG	POWDER / INHALATION	RLD, RS	2018-12-21	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N209184-001	INBRIJA	42MG	POWDER / INHALATION	RLD, RS	2018-12-21	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	N209184-001	INBRIJA	42MG	POWDER / INHALATION	RLD, RS	2018-12-21	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	N209184-001	INBRIJA	42MG	POWDER / INHALATION	RLD, RS	2018-12-21	`e64feba35796…`

Observed Orange Book patent history#

Patent history page 1 of 10 · 395 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Patent	Expiration	Use code	Coverage / status	Submission date	Source SHA-256
2026-08-18 06:07:40	2026-07	N209184-001	RE43711	2029-02-03	U-2484		2019-01-18	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N209184-001	8545878	2032-11-16		Drug product	2019-01-18	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N209184-001	8685442	2032-11-16		Drug product	2019-01-18	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N209184-001	8945612	2032-11-16		Drug product	2019-01-18	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N209184-001	9393210	2032-11-16		Drug product	2019-01-18	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N209184-001	12458615	2033-10-21	U-2484		2025-11-26	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N209184-001	RE43711	2029-02-03	U-2484		2019-01-18	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N209184-001	8545878	2032-11-16		Drug product	2019-01-18	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N209184-001	8685442	2032-11-16		Drug product	2019-01-18	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N209184-001	8945612	2032-11-16		Drug product	2019-01-18	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N209184-001	9393210	2032-11-16		Drug product	2019-01-18	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N209184-001	12458615	2033-10-21	U-2484		2025-11-26	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N209184-001	RE43711	2029-02-03	U-2484		2019-01-18	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N209184-001	8545878	2032-11-16		Drug product	2019-01-18	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N209184-001	8685442	2032-11-16		Drug product	2019-01-18	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N209184-001	8945612	2032-11-16		Drug product	2019-01-18	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N209184-001	9393210	2032-11-16		Drug product	2019-01-18	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N209184-001	RE43711	2029-02-03	U-2484		2019-01-18	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N209184-001	8545878	2032-11-16		Drug product	2019-01-18	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N209184-001	8685442	2032-11-16		Drug product	2019-01-18	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N209184-001	8945612	2032-11-16		Drug product	2019-01-18	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N209184-001	9393210	2032-11-16		Drug product	2019-01-18	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N209184-001	RE43711	2029-02-03	U-2484		2019-01-18	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N209184-001	8545878	2032-11-16		Drug product	2019-01-18	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N209184-001	8685442	2032-11-16		Drug product	2019-01-18	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N209184-001	8945612	2032-11-16		Drug product	2019-01-18	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N209184-001	9393210	2032-11-16		Drug product	2019-01-18	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N209184-001	RE43711	2029-02-03	U-2484		2019-01-18	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N209184-001	8545878	2032-11-16		Drug product	2019-01-18	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N209184-001	8685442	2032-11-16		Drug product	2019-01-18	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N209184-001	8945612	2032-11-16		Drug product	2019-01-18	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N209184-001	9393210	2032-11-16		Drug product	2019-01-18	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N209184-001	7182961	2024-02-22		Drug product	2019-01-18	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N209184-001	RE43711	2029-02-03	U-2484		2019-01-18	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N209184-001	8545878	2032-11-16		Drug product	2019-01-18	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N209184-001	8685442	2032-11-16		Drug product	2019-01-18	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N209184-001	8945612	2032-11-16		Drug product	2019-01-18	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N209184-001	9393210	2032-11-16		Drug product	2019-01-18	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N209184-001	7182961	2024-02-22		Drug product	2019-01-18	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N209184-001	RE43711	2029-02-03	U-2484		2019-01-18	`2680178bc6a6…`

Observed Orange Book exclusivity history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	Exclusivity code	Expiration	Source SHA-256
2019-12-13 00:20 UTC	2019-12	N209184-001	NP	2021-12-21	`74a2ff9319b5…`
2021-12-28 21:50 UTC	2021-12	N209184-001	NP	2021-12-21	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N209184-001	NP	2021-12-21	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N209184-001	NP	2021-12-21	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N209184-001	NP	2021-12-21	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N209184-001	NP	2021-12-21	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N209184-001	NP	2021-12-21	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N209184-001	NP	2021-12-21	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N209184-001	NP	2021-12-21	`ea99ee380514…`

Additional Listing Data#

Finished product: Yes
Brand name base: Inbrija
Listing expiration: 2027-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
LEVODOPA	42 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
46627O600J	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
2107616	Internal RxNorm lookup
2107621	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
077c0f39-a3a2-4b2b-a184-09131889dcfb	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
5ce6fab2-d006-4589-8ba0-02cee499cc60	Product name	2	20260128
ebf3b793-6fcd-797b-9d2e-c3faf6d29442	Product name	5	20251106
162160fe-5ea6-4f9d-aa38-c4b780c57046	Product name	1	20250515
0e5ae331-9620-4d1f-8061-7c437c7f1c42	Product name	1	20250312
028fdaca-77da-0dfe-e445-7dfc440fc97e	Product name	4	20250224
362d7abb-94e6-4c60-9a58-266894157713	Product name	1	20231023
6bd95106-a412-1dad-b9cc-4cb74bfb27ce	Product name	2	20230315
de702a02-e9c0-4daf-9101-e44f2c0d4e66	Product name	1	20220609
f1e0dc7e-7d61-4625-b6d9-4894927679d7	Product name	2	20211025
e4870509-7e28-6f92-f0be-dd3dd889a9cf	Product name	5	20200810
6e9d4a47-c464-b93e-aebc-ad7bffc9c4cd	Product name	2	20190619
444b3e50-f226-46ef-bfca-2e7035d140cd	Product name	1	20190611
816b97af-edc5-4060-aff1-b814bdbcad50	Product name	1	20190415
681917df-580c-4199-896d-b739fbb25ed3	Product name	1	20190412
7cda52fc-125f-421c-8fea-bc1974370c49	Product name	2	20180703
419aab54-5d5a-4146-9453-026d4a9991be	Product name	2	20170525
d5e51f11-ad28-caa4-4b49-4143974782ad	Product name	1	20150831
290f523a-f9db-9774-b5a9-e1f908ac1782	Product name	1	20150828
89dac932-b90a-4410-9ab1-84c53e57de25	Product name	1	20150316
1fa100ae-9ab3-4df0-afe7-33ab01fd4a41	Product name	1	20150313
88839c8d-b65b-4a50-997b-4c74539855ff	Product name	1	20150313
5668b646-cd56-c3c7-bdea-3f6b1a8840db	Product name	1	20140508
684ea482-2e8b-14af-5664-b98f1e402036	Product name	1	20140508
810ab97e-f109-f41c-7c83-6a652a9cbf43	Product name	1	20140508
87711080-88eb-65c5-b2dd-bf99e700a372	Product name	1	20140508
8dbefedf-0a0d-a224-5a3c-66dc9e11c2dd	Product name	1	20140508
b060cc1a-fe47-856b-0b77-4448b5963de8	Product name	1	20140508
c6b65c52-69c7-df49-550a-a50c137f6218	Product name	1	20140508
ec2149b3-5c6d-5344-f757-c86411073075	Product name	1	20140508
ed912195-5da0-0f2f-6f4b-3ef17710cbe3	Product name	1	20140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
0259-6142-01	Inbrija	4 in 1 BLISTER PACK	CAPSULE	4	1
0259-6142-16	Inbrija	4 in 1 CARTON	CAPSULE	4	1
0259-6142-32	Inbrija	8 in 1 CARTON	CAPSULE	8	1
0259-6142-60	Inbrija	15 in 1 CARTON	CAPSULE	15	1

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Inbrija	LEVODOPA	Merz Pharmaceuticals, LLC	077c0f39-a3a2-4b2b-a184-09131889dcfb	2026-07-20	Warnings, Adverse reactions	Exact identifier application applno (NDA): 209184 application number: NDA209184 ndc (product): 0259-6142
Inbrija	LEVODOPA	Merz Pharmaceuticals, LLC	a906f8e1-6e1c-480a-8276-c01bc65dd3be	2026-01-16	Warnings, Adverse reactions	Exact identifier application applno (NDA): 209184 application number: NDA209184

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
46627O600J	LEVODOPA	59-92-7	LEVODOPA

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
2107621	Inbrija 42 MG Inhalation Powder Capsule	PSN	077c0f39-a3a2-4b2b-a184-09131889dcfb	1
2107616	levodopa 42 MG Inhalation Powder Capsule	PSN	077c0f39-a3a2-4b2b-a184-09131889dcfb	1
2107621	levodopa 42 MG Inhalation Powder [Inbrija]	SBD	077c0f39-a3a2-4b2b-a184-09131889dcfb	1
2107616	levodopa 42 MG Inhalation Powder	SCD	077c0f39-a3a2-4b2b-a184-09131889dcfb	1
2107621	Inbrija 42 MG Inhalation Powder	SY	077c0f39-a3a2-4b2b-a184-09131889dcfb	1
2107616	L-DOPA 42 MG Inhalation Powder	SY	077c0f39-a3a2-4b2b-a184-09131889dcfb	1
2107621	L-DOPA 42 MG Inhalation Powder [Inbrija]	SY	077c0f39-a3a2-4b2b-a184-09131889dcfb	1

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Sample	Exclude flag	Status
0259-6142-01	00259614201	4 in 1 BLISTER PACK					Historical
0259-6142-16	00259614216	4 BLISTER PACK in 1 CARTON (0259-6142-16) / 4 CAPSULE in 1 BLISTER PACK (0259-6142-01)	4 blister pack	2018-12-22	Yes	No	Current
0259-6142-32	00259614232	8 BLISTER PACK in 1 CARTON (0259-6142-32) / 4 CAPSULE in 1 BLISTER PACK (0259-6142-01)	8 blister pack	2018-12-22	Yes	No	Current
0259-6142-60	00259614260	15 BLISTER PACK in 1 CARTON (0259-6142-60) / 4 CAPSULE in 1 BLISTER PACK (0259-6142-01)	15 blister pack	2018-12-22	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Inbrija - Merz Pharmaceuticals, LLC \| Avista Pharma Solutions, Inc.	Merz Pharmaceuticals, LLC \| Avista Pharma Solutions, Inc.	2026-07-20	HUMAN PRESCRIPTION DRUG LABEL	2